Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000068

Director sold 150,000 shares at $5.92 ($888,540)

  • Director acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KRIEGSMAN STEVEN A Director 2014-01-23 Option exercise +100,000 $1.18 $118,000 105,000 D
KRIEGSMAN STEVEN A Director 2014-01-23 Option exercise +50,000 $2.31 $115,500 155,000 D
KRIEGSMAN STEVEN A Director 2014-01-23 Sale −150,000 $5.92 $888,540 5,000 D
Derivatives
KRIEGSMAN STEVEN A Director 2014-01-23 Option exercise · Stock Option (right to buy) −100,000 0 D
KRIEGSMAN STEVEN A Director 2014-01-23 Option exercise · Stock Option (right to buy) −50,000 0 D
Open-market sales · 150,000 sh · avg $5.92 · $888,540
Loading xslF345X03/primary_doc.xml…